Nycomed’s Instanyl is first intranasal fentanyl approved in Europe for managing breakthrough pain in cancer

July 24, 2009--Nycomed today announced that the European Commission has granted marketing authorisation for Instanyl®, its first-in-class intranasal fentanyl spray.

The details can be read here.